Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation
- 4 May 2004
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 275 (1-2) , 61-72
- https://doi.org/10.1016/j.ijpharm.2004.01.030
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antifungal drug resistance to azoles and polyenesThe Lancet Infectious Diseases, 2002
- Invasive fungal infections: evolving challenges for diagnosis and therapeuticsMolecular Immunology, 2002
- Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymersJournal of Controlled Release, 2001
- Current and future antifungal therapy: new targets for antifungal therapyInternational Journal of Antimicrobial Agents, 2000
- Antimicrobial Nonapeptide Leucinostatin A-Dependent Effects on the Physical Properties of Phospholipid Model MembranesJournal of Colloid and Interface Science, 2000
- Antifungal Peptides: Novel Therapeutic Compounds against Emerging PathogensAntimicrobial Agents and Chemotherapy, 1999
- Human defenses against Cryptococcus neoformans: An updateMycopathologia, 1998
- The nonapeptide leucinostatin A acts as a weak ionophore and as an immunosuppressant on T lymphocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Infections with Aspergillus SpeciesClinical Infectious Diseases, 1993
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992